StockNews.com initiated coverage on shares of Pro-Dex (NASDAQ:PDEX – Get Rating) in a research report released on Monday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock.
Pro-Dex Stock Performance
NASDAQ:PDEX opened at $17.80 on Monday. The company’s 50-day moving average price is $18.05 and its 200-day moving average price is $17.04. The company has a current ratio of 2.73, a quick ratio of 1.39 and a debt-to-equity ratio of 0.41. The company has a market cap of $63.72 million, a P/E ratio of 17.12 and a beta of 0.94. Pro-Dex has a twelve month low of $12.40 and a twelve month high of $26.50.
Pro-Dex (NASDAQ:PDEX – Get Rating) last released its quarterly earnings data on Thursday, August 25th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter. Pro-Dex had a net margin of 8.97% and a return on equity of 16.75%. The firm had revenue of $12.62 million during the quarter.
Institutional Trading of Pro-Dex
Pro-Dex Company Profile
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
- Get a free copy of the StockNews.com research report on Pro-Dex (PDEX)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.